Work

Prognostic Value of CA 19-9 in a Phase I/II Trial of Dose Escalated Intensity Modulated Radiation Therapy (IMRT) With Concurrent Full-dose Gemcitabine (G) in Unresectable Pancreatic Cancer

Year: 2012

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2012.07.378

Authors: J.M. Vainshtein, M. Schipper, M. Zalupski, T.S. Lawrence, R. Abrams, I.R. Francis, W. Leslie, E. Ben-Josef

Institutions: University of Michigan, Michigan Medicine, Rush University Medical Center, University of Pennsylvania

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1979974694

FWCI:

Cites:

Cited by:

Related to: 10